Product Code: GVR-4-68040-028-9
Analytical Instrumentation Market Summary
The global analytical instrumentation market size was valued at USD 57.7 billion in 2025 and is anticipated to reach USD 90.5 billion by 2033, growing at a CAGR of 5.9% from 2026 to 2033. Rising requirements for accurate quality assurance, ongoing innovations in research and development, stricter regulatory standards, and broader adoption across sectors such as pharmaceuticals, environmental monitoring, food safety, and chemicals primarily drive market expansion.
Global Analytical Instrumentation Market Report Segmentation
This report forecasts revenue growth at global, regional and country levels, and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the analytical instrumentation market on the basis of product, technology, application, and region.
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Instruments
- Services
- Software
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Polymerase Chain Reaction
- Spectroscopy
- Microscopy
- Chromatography
- Flow Cytometry
- Sequencing
- Microarray
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Life Sciences Research & Development
- Clinical & Diagnostic Analysis
- Food & Beverage Analysis
- Forensic Analysis
- Environmental Testing
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Application
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.3.1. Market Driver Impact Analysis
- 3.3.1.1. Technological innovation
- 3.3.1.2. Rising emphasis on quality control and safety
- 3.3.1.3. Increasing adoption of analytical instrumentation for precision medicine applications
- 3.3.2. Market Restraint Impact Analysis
- 3.3.2.1. High cost of instruments
- 3.3.2.2. Stringent regulatory and compliance requirements
- 3.3.3. Market Challenges Analysis
- 3.3.4. Market Opportunity Analysis
- 3.4. Case Study Insights
- 3.5. Business Environment Analysis
- 3.5.1. PESTLE Analysis
- 3.5.2. PORTER'S Five Forces Analysis
Chapter 4. Product Business Analysis
- 4.1. Product Segment Dashboard
- 4.2. Global Analytical Instrumentation Market Product, Movement Analysis
- 4.3. Global Analytical Instrumentation Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
- 4.4. Instruments
- 4.4.1. Global instruments market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5. Services
- 4.5.1. Global services market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.6. Software
- 4.6.1. Global software market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Technology Business Analysis
- 5.1. Technology Segment Dashboard
- 5.2. Global Analytical Instrumentation Market Technology, Movement Analysis
- 5.3. Global Analytical Instrumentation Market Size & Trend Analysis, by Technology, 2021 - 2033 (USD Million)
- 5.4. Polymerase Chain Reaction
- 5.4.1. Global Polymerase Chain Reaction Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Spectroscopy
- 5.5.1. Global Spectroscopy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Microscopy
- 5.6.1. Global Microscopy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Chromatography
- 5.7.1. Global Chromatography Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8. Flow Cytometry
- 5.8.1. Global Flow Cytometry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.9. Sequencing
- 5.9.1. Global Sequencing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.10. Microarray
- 5.10.1. Global Microarray Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.11. Others
- 5.11.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Application Business Analysis
- 6.1. Application Segment Dashboard
- 6.2. Global Analytical Instrumentation Market Application, Movement Analysis
- 6.3. Global Analytical Instrumentation Market Size & Trend Analysis, by Application, 2021 - 2033 (USD Million)
- 6.4. Life Sciences Research & Development
- 6.4.1. Global Life Sciences Research & Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Clinical & Diagnostic Analysis
- 6.5.1. Global Clinical & Diagnostic Analysis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Food & Beverage Analysis
- 6.6.1. Global Food & Beverage Analysis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. Forensic Analysis
- 6.7.1. Global Forensic Analysis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8. Environmental Testing
- 6.8.1. Global Environmental Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.9. Others
- 6.9.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Analytical Instrumentation Market: Regional Estimates and Trend Analysis, by Product, Technology, & Application
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts and Trend Analysis, 2021 - 2033
- 7.3. North America
- 7.3.1. North America Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. Target Disease Prevalence
- 7.3.2.5. U.S. Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Target Disease Prevalence
- 7.3.3.5. Canada Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. Target Disease Prevalence
- 7.3.4.5. Mexico Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Target Disease Prevalence
- 7.4.2.5. UK Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. Target Disease Prevalence
- 7.4.3.5. Germany Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. Target Disease Prevalence
- 7.4.4.5. France Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Target Disease Prevalence
- 7.4.5.5. Italy Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Target Disease Prevalence
- 7.4.6.5. Spain Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Target Disease Prevalence
- 7.4.7.5. Denmark Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Competitive Scenario
- 7.4.8.3. Regulatory Framework
- 7.4.8.4. Target Disease Prevalence
- 7.4.8.5. Sweden Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key Country Dynamics
- 7.4.9.2. Competitive Scenario
- 7.4.9.3. Regulatory Framework
- 7.4.9.4. Target Disease Prevalence
- 7.4.9.5. Norway Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Target Disease Prevalence
- 7.5.2.5. Japan Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Target Disease Prevalence
- 7.5.3.5. China Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. Target Disease Prevalence
- 7.5.4.5. India Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. Target Disease Prevalence
- 7.5.5.5. South Korea Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.5.6. Australia
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Target Disease Prevalence
- 7.5.6.5. Australia Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Target Disease Prevalence
- 7.5.7.5. Thailand Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Target Disease Prevalence
- 7.6.2.5. Brazil Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Target Disease Prevalence
- 7.6.3.5. Argentina Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.7. MEA
- 7.7.1. MEA Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Target Disease Prevalence
- 7.7.2.5. South Africa Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Target Disease Prevalence
- 7.7.3.5. Saudi Arabia Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. Target Disease Prevalence
- 7.7.4.5. UAE Analytical Instrumentation Market, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Target Disease Prevalence
- 7.7.5.5. Kuwait Analytical Instrumentation Market, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2025
- 8.4. Company Profiles/Listing
- 8.4.1. Thermo Fisher Scientific, Inc.
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Waters Corp.
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Shimadzu Corp.
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Danaher
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Agilent Technologies, Inc.
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Bruker Corp.
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. PerkinElmer, Inc.
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Mettler Toledo
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Zeiss Group
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Bio-Rad Laboratories, Inc.
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives
- 8.4.11. Illumina, Inc.
- 8.4.11.1. Overview
- 8.4.11.2. Financial Performance
- 8.4.11.3. Product Benchmarking
- 8.4.11.4. Strategic Initiatives
- 8.4.12. Eppendorf SE
- 8.4.12.1. Overview
- 8.4.12.2. Financial Performance
- 8.4.12.3. Product Benchmarking
- 8.4.12.4. Strategic Initiatives
- 8.4.13. F. Hoffmann-La Roche AG
- 8.4.13.1. Overview
- 8.4.13.2. Financial Performance
- 8.4.13.3. Product Benchmarking
- 8.4.13.4. Strategic Initiatives
- 8.4.14. Sartorius AG
- 8.4.14.1. Overview
- 8.4.14.2. Financial Performance
- 8.4.14.3. Product Benchmarking
- 8.4.14.4. Strategic Initiatives
- 8.4.15. Avantor, Inc.
- 8.4.15.1. Overview
- 8.4.15.2. Financial Performance
- 8.4.15.3. Product Benchmarking
- 8.4.15.4. Strategic Initiatives